TD Securities analyst Vince Valentini downgrades TELUS (NYSE:TU) from Buy to Hold.
Heat Biologics Shares Spiked Higher Midday, Now Up ~2%; Recent Zack’s Small Cap Research Report Suggested $19 Valuation Target On Stock
https://s27.q4cdn.com/906368049/files/News/2022/Zacks_SCR_Research_01132022_HTBX_Vandermosten.pdf